Non Government Organizations
Diabetes and Immune Tolerance
Research into the etiology and potential treatments for diabetes is one of the major areas of research supported by the RUCDR, involving partnerships with a number of agencies. As part of this effort, we isolate peripheral blood mononuclear cells (PBMCs) for cryopreservation, storage, and distribution to the diabetes research community.
The Immune Tolerance Network
The Immune Tolerance Network is an organization born from the collective vision of the National Institutes of Health and the tolerance research community. Its mission is to advance the clinical application of immune tolerance by performing high quality clinical trials of emerging therapeutics integrated with mechanism-based research. In particular, ITN aims to establish new tolerance therapeutics, develop a better understanding of the mechanisms of immune function and disease pathogenesis, and identify new biomarkers of tolerance and disease. In partnership with ITN, RUCDR has initiated the biobank and will receive and process blood samples from all participating ITN collection sites. For more information, visit our partner's website.